{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:04:02Z","timestamp":1767143042434,"version":"build-2238731810"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T00:00:00Z","timestamp":1454112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Les Laboratoires Servier, Saudi Arabia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s40261-015-0370-y","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T05:35:46Z","timestamp":1454132146000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Efficacy of Perindopril\/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Ayman","family":"Abdelhady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Khader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Sinnuqrut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Albow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,30]]},"reference":[{"key":"370_CR1","doi-asserted-by":"crossref","unstructured":"Groha P, et al. New ESH\/ESC guidelines on arterial hypertension: what is new and what indications remain for renal denervation?. Herz. 2014;39(8):952\u2013956.","DOI":"10.1007\/s00059-014-4178-y"},{"issue":"3","key":"370_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/0929867321666141106113018","volume":"22","author":"J Tamargo","year":"2014","unstructured":"Tamargo J, Duarte J, Ruilope LM. New antihypertensive drugs under development. Curr Med Chem. 2014;22(3):305\u201342.","journal-title":"Curr Med Chem"},{"issue":"9765","key":"370_CR3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(10)62036-3","volume":"377","author":"G Danaei","year":"2011","unstructured":"Danaei G, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet. 2011;377(9765):568\u201377.","journal-title":"Lancet"},{"key":"370_CR4","unstructured":"World Health Organization (WHO). Global status report on noncommunicable diseases. 2014. http:\/\/www.who.int\/nmh\/publications\/ncd-status-report-2014\/en\/ . Retrieved 17 Nov 2014."},{"key":"370_CR5","doi-asserted-by":"crossref","first-page":"174135","DOI":"10.4061\/2011\/174135","volume":"2011","author":"AA Saeed","year":"2011","unstructured":"Saeed AA, et al. Prevalence, Awareness, treatment, and control of hypertension among Saudi adult population: a national survey. Int J Hypertens. 2011;2011:174135.","journal-title":"Int J Hypertens"},{"key":"370_CR6","doi-asserted-by":"crossref","first-page":"564679","DOI":"10.1155\/2014\/564679","volume":"2014","author":"C Bcheraoui El","year":"2014","unstructured":"El Bcheraoui C, et al. Hypertension and its associated risk factors in the kingdom of saudi arabia, 2013: a national survey. Int J Hypertens. 2014;2014:564679.","journal-title":"Int J Hypertens"},{"issue":"21","key":"370_CR7","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"C Rosendorff","year":"2007","unstructured":"Rosendorff C, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115(21):2761\u201388.","journal-title":"Circulation"},{"issue":"5","key":"370_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","journal-title":"JAMA"},{"issue":"7653","key":"370_CR9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336(7653):1121\u20133.","journal-title":"BMJ"},{"key":"370_CR10","doi-asserted-by":"crossref","unstructured":"Fontana V, Luizon MR, Sandrim VC. An update on the pharmacogenetics of treating hypertension. J Hum Hypertens. 2014;29:283\u201391.","DOI":"10.1038\/jhh.2014.76"},{"key":"370_CR11","doi-asserted-by":"crossref","unstructured":"Diao D, et al. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev. 2012;8:CD006742.","DOI":"10.1002\/14651858.CD006742.pub2"},{"issue":"4","key":"370_CR12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2009.1060","volume":"302","author":"JP Forman","year":"2009","unstructured":"Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009;302(4):401\u201311.","journal-title":"JAMA"},{"issue":"1","key":"370_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jash.2010.02.005","volume":"4","author":"AH Gradman","year":"2010","unstructured":"Gradman AH, et al. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4(1):42\u201350.","journal-title":"J Am Soc Hypertens"},{"issue":"3","key":"370_CR14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290\u2013300.","journal-title":"Am J Med"},{"issue":"28","key":"370_CR15","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"issue":"23","key":"370_CR16","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417\u201328.","journal-title":"N Engl J Med"},{"issue":"9","key":"370_CR17","first-page":"603","volume":"32","author":"R Hatala","year":"2012","unstructured":"Hatala R, et al. Optimization of blood pressure treatment with fixed-combination perindopril\/amlodipine in patients with arterial hypertension. Clin Drug Investig. 2012;32(9):603\u201312.","journal-title":"Clin Drug Investig"},{"issue":"3","key":"370_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03256570","volume":"9","author":"VK Bahl","year":"2009","unstructured":"Bahl VK, Jadhav UM, Thacker HP. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study. Am J Cardiovasc Drugs. 2009;9(3):135\u201342.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6","key":"370_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","volume":"4","author":"WC Cushman","year":"2002","unstructured":"Cushman WC, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4(6):393\u2013404.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"370_CR20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.HYP.36.4.594","volume":"36","author":"DM Lloyd-Jones","year":"2000","unstructured":"Lloyd-Jones DM, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36(4):594\u20139.","journal-title":"Hypertension"},{"issue":"2","key":"370_CR21","first-page":"148","volume":"19","author":"MV McDonald","year":"2009","unstructured":"McDonald MV, et al. Understanding the complexity of hypertensive African American home care patients: challenges to intervention. Ethn Dis. 2009;19(2):148\u201353.","journal-title":"Ethn Dis"},{"issue":"10","key":"370_CR22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjhyper.2004.05.016","volume":"17","author":"TG Majernick","year":"2004","unstructured":"Majernick TG, et al. Correlates of hypertension control in a primary care setting. Am J Hypertens. 2004;17(10):915\u201320.","journal-title":"Am J Hypertens"},{"issue":"3","key":"370_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/dc12-0755","volume":"36","author":"DM Cummings","year":"2013","unstructured":"Cummings DM, et al. Generic medications and blood pressure control in diabetic hypertensive subjects: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Diabetes Care. 2013;36(3):591\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"370_CR24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/HYPERTENSIONAHA.107.107342","volume":"51","author":"S Keyhani","year":"2008","unstructured":"Keyhani S, et al. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51(4):1149\u201355.","journal-title":"Hypertension"},{"issue":"12","key":"370_CR25","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1097\/HJH.0000000000000350","volume":"32","author":"A Solini","year":"2014","unstructured":"Solini A, et al. Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications. J Hypertens. 2014;32(12):2401\u201310.","journal-title":"J Hypertens"},{"issue":"5","key":"370_CR26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/jwh.2005.14.418","volume":"14","author":"MK Duggirala","year":"2005","unstructured":"Duggirala MK, et al. Women with diabetes have poorer control of blood pressure than men. J Womens Health (Larchmt). 2005;14(5):418\u201323.","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"370_CR27","doi-asserted-by":"crossref","first-page":"H466","DOI":"10.1152\/ajpheart.01232.2007","volume":"295","author":"A Lopez-Ruiz","year":"2008","unstructured":"Lopez-Ruiz A, et al. Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am J Physiol Heart Circ Physiol. 2008;295(2):H466\u201374.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"370_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.dsx.2013.02.019","volume":"7","author":"SS Abougalambou","year":"2013","unstructured":"Abougalambou SS, Abougalambou AS. A study evaluating prevalence of hypertension and risk factors affecting on blood pressure control among type 2 diabetes patients attending teaching hospital in Malaysia. Diabetes Metab Syndr. 2013;7(2):83\u20136.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"370_CR29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0256-4947.51684","volume":"28","author":"FM Mubarak","year":"2008","unstructured":"Mubarak FM, et al. Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann Saudi Med. 2008;28(5):346\u201351.","journal-title":"Ann Saudi Med"},{"issue":"3","key":"370_CR30","first-page":"313","volume":"31","author":"N Serra","year":"2011","unstructured":"Serra N, et al. Factors associated with blood pressure control in diabetic patients treated in nephrology units. PRESDIAB Study. Nefrologia. 2011;31(3):313\u201321.","journal-title":"Nefrologia"},{"key":"370_CR31","unstructured":"Barquilla Garcia A, et al. Blood pressure control in a population of hypertensive diabetic patients treated in primary care: PRESCAP-Diabetes Study 2010. Semergen. 2014;41(1):13\u201323."},{"key":"370_CR32","doi-asserted-by":"crossref","unstructured":"Mutua EM, et al. Level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital in Central Kenya. Pan Afr Med J. 2014;18:278.","DOI":"10.11604\/pamj.2014.18.278.4308"},{"issue":"2","key":"370_CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jash.2013.01.006","volume":"7","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, et al. Effect of a fixed combination of Perindopril and Amlodipine on blood pressure control in 6256 patients with not-at-goal hypertension: the AVANT\u2019AGE study. J Am Soc Hypertens. 2013;7(2):163\u20139.","journal-title":"J Am Soc Hypertens"}],"updated-by":[{"DOI":"10.1007\/s40261-016-0391-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000}}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0370-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0370-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:28:57Z","timestamp":1559489337000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0370-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,30]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0370-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,30]]}}}